APA (7th ed.) Citation

Spratt, D., Dess, R., Efstathiou, J., Zietman, A., Wallington, D., Jairath, N., . . . Shipley, W. (2019). Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy: A Secondary Analysis of the NRG Oncology/RTOG 9601 Randomized Phase III Trial. International Journal of Radiation Oncology, Biology, Physics, 105(3), 680. https://doi.org/10.1016/j.ijrobp.2019.08.029

Chicago Style (17th ed.) Citation

Spratt, D.E, et al. "Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy: A Secondary Analysis of the NRG Oncology/RTOG 9601 Randomized Phase III Trial." International Journal of Radiation Oncology, Biology, Physics 105, no. 3 (2019): 680. https://doi.org/10.1016/j.ijrobp.2019.08.029.

MLA (9th ed.) Citation

Spratt, D.E, et al. "Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy: A Secondary Analysis of the NRG Oncology/RTOG 9601 Randomized Phase III Trial." International Journal of Radiation Oncology, Biology, Physics, vol. 105, no. 3, 2019, p. 680, https://doi.org/10.1016/j.ijrobp.2019.08.029.